Breast Cancer Cell Density: Imaging assay of the density- and context-dependence of small molecule perturbagen response in breast cancer cell lines. Dataset 1 of 3: Cell count and normalized growth rate inhibition values. - Dataset (ID:20256)
Download: Excel (XLSX), Comma-separated (CSV)
Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | Replicate | Seeding Density | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value |
---|---|---|---|---|---|---|---|---|---|---|
SK-BR-3 | Omipalisib | 0.01 | uM | 4 | 156.25 | 63.10 | 33.00 | 77.75 | 0.4244 | -0.8839 |
SK-BR-3 | Omipalisib | 3.1623 | uM | 4 | 156.25 | 63.10 | 42.00 | 77.75 | 0.5402 | -0.7413 |
SK-BR-3 | 0 | uM | 4 | 156.25 | 63.10 | 85.00 | 77.75 | 1.0932 | 1.6892 | |
SK-BR-3 | 0 | uM | 4 | 156.25 | 63.10 | 69.00 | 77.75 | 0.8875 | 0.3453 | |
SK-BR-3 | 0 | uM | 4 | 312.50 | 180.13 | 237.00 | 259.50 | 0.9133 | 0.6837 | |
SK-BR-3 | 0 | uM | 4 | 312.50 | 180.13 | 210.00 | 259.50 | 0.8093 | 0.3382 | |
SK-BR-3 | Methotrexate | 0.031623 | uM | 4 | 312.50 | 180.13 | 251.00 | 259.50 | 0.9672 | 0.8775 |
SK-BR-3 | Omipalisib | 1 | uM | 4 | 312.50 | 180.13 | 112.00 | 259.50 | 0.4316 | -0.5943 |
SK-BR-3 | Methotrexate | 0.1 | uM | 4 | 312.50 | 180.13 | 298.00 | 259.50 | 1.1484 | 1.6007 |
SK-BR-3 | Taxol | 0.031623 | uM | 4 | 312.50 | 180.13 | 122.00 | 259.50 | 0.4701 | -0.5228 |
SK-BR-3 | Palbociclib | 10 | uM | 4 | 312.50 | 180.13 | 128.00 | 259.50 | 0.4933 | -0.4772 |
SK-BR-3 | Palbociclib | 0.0033113 | uM | 4 | 312.50 | 180.13 | 216.00 | 259.50 | 0.8324 | 0.4117 |
SK-BR-3 | Taxol | 0.01 | uM | 4 | 312.50 | 180.13 | 153.00 | 259.50 | 0.5896 | -0.2665 |
SK-BR-3 | Palbociclib | 3.1623 | uM | 4 | 312.50 | 180.13 | 174.00 | 259.50 | 0.6705 | -0.0636 |
SK-BR-3 | Methotrexate | 0.01 | uM | 4 | 312.50 | 180.13 | 233.00 | 259.50 | 0.8979 | 0.6301 |
SK-BR-3 | Taxol | 0.00016596 | uM | 4 | 312.50 | 180.13 | 334.00 | 259.50 | 1.2871 | 2.2294 |
SK-BR-3 | Taxol | 0.00033113 | uM | 4 | 312.50 | 180.13 | 345.00 | 259.50 | 1.3295 | 2.4343 |
SK-BR-3 | Palbociclib | 0.1 | uM | 4 | 312.50 | 180.13 | 208.00 | 259.50 | 0.8015 | 0.3141 |
SK-BR-3 | Omipalisib | 10 | uM | 4 | 312.50 | 180.13 | 98.00 | 259.50 | 0.3777 | -0.6851 |
SK-BR-3 | 0 | uM | 4 | 312.50 | 180.13 | 282.00 | 259.50 | 1.0867 | 1.3420 | |
SK-BR-3 | Palbociclib | 1 | uM | 4 | 312.50 | 180.13 | 187.00 | 259.50 | 0.7206 | 0.0737 |
SK-BR-3 | Methotrexate | 3.1623 | uM | 4 | 312.50 | 180.13 | 274.00 | 259.50 | 1.0559 | 1.2175 |
SK-BR-3 | Omipalisib | 0.0033113 | uM | 4 | 312.50 | 180.13 | 181.00 | 259.50 | 0.6975 | 0.0092 |
SK-BR-3 | Omipalisib | 0.0016596 | uM | 4 | 312.50 | 180.13 | 195.00 | 259.50 | 0.7515 | 0.1626 |
SK-BR-3 | Palbociclib | 0.31623 | uM | 4 | 312.50 | 180.13 | 180.00 | 259.50 | 0.6936 | -0.0013 |